Abstract
Faropenem was tested against 1,188 middle ear fluid pathogens from children in Israel and Costa Rica. Against Streptococcus pneumoniae and Haemophilus influenzae, faropenem was the most active β-lactam, with activity that was similar to or greater than of the other oral antimicrobial classes studied. Faropenem was also active against Moraxella catarrhalis and Streptococcus pyogenes.
Original language | English |
---|---|
Pages (from-to) | 2230-2235 |
Number of pages | 6 |
Journal | Antimicrobial Agents and Chemotherapy |
Volume | 51 |
Issue number | 6 |
DOIs | |
State | Published - 1 Jun 2007 |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases